glp-1 obesity cardiovascular news The Big Trial of a drug (Wegovy) to Reduce Major Events Semaglutide Shows Secondary Cardiovascular Prevention

While it is not as effective as injectable GLP-1 agonists, orforglipron is more convenient to use and is cheaper to produce

The insurance company stopped covering GLP-1 medications for weight loss due to cost concerns, and now offers all US employees free gym memberships.

Stigma surrounding GLP-1 weight loss treatments reveals societal biases, impacting individuals' mental health and the effectiveness of obesity interventions.

This hormone plays a vital role in blood sugar regulation and appetite control, making it especially important in the context of metabolic health and weight management

PlexusDx explains proper timing protocols and what to do if you miss a dose